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Long-lived antibody memory is mediated by the combined effects of long-lived plasma cells (PCs) 
and memory B cells generated in response to T cell–dependent antigens (Ags). IL-0 and IL-2 can 
activate multiple signaling pathways, including STAT, STAT3, and STAT5; ERK; PI3K/Akt, and 
potently promote human B cell differentiation. We previously showed that loss-of-function muta-
tions in STAT3, but not STAT, abrogate IL-0– and IL-2–mediated differentiation of human naive 
B cells into plasmablasts. We report here that, in contrast to naive B cells, STAT3-deficient memory 
B cells responded to these STAT3-activating cytokines, differentiating into plasmablasts and secret-
ing high levels of IgM, IgG, and IgA, as well as Ag-specific IgG. This was associated with the induc-
tion of the molecular machinery necessary for PC formation. Mutations in IL2R, however, abolished 
IL-2–induced responses of both naive and memory human B cells and compromised memory B cell 
formation in vivo. These findings reveal a key role for IL-2R/STAT3 signaling in regulating human  
B cell function. Furthermore, our results indicate that the threshold of STAT3 activation required for 
differentiation is lower in memory compared with naive B cells, thereby identifying an intrinsic 
difference in the mechanism underlying differen-
tiation of naive versus memory B cells.
© 2013 Deenick et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the 
publication date (see http://www.rupress.org/terms). After six months it is available 
under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported 
license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).E.K. Deenick and D.T. Avery contributed equally to this paper.
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Pène et al., 2004; Ettinger et al., 2005; Bryant et al., 2007; 
Avery et al., 2008a,b). Although the functions of IL-10 and 
IL-21 on human B cells are similar, the effects of IL-21 
exceed those of IL-10 by 10–100-fold (Bryant et al., 2007). 
The importance of IL-21 to immune regulation has been 
validated by the recent identification of IL-21R–deficient 
humans, who exhibit infectious susceptibility to several 
pathogens (Kotlarz et al., 2013). The predominance of IL-21 
in regulating human B cell function over IL-10 is also indi-
cated by the fact that IL21R mutations result in poor Ab re-
sponses after vaccination (Kotlarz et al., 2013), whereas 
specific Abs are produced at normal levels in individuals with 
mutations in IL10/IL10R (Kotlarz et al., 2012). IL-10 and 
IL-21 activate STAT1, STAT3, STAT5, as well as MAPK/
ERK and PI3K/Akt pathways (Asao et al., 2001; Zeng et al., 
2007; Avery et al., 2008b, 2010; Diehl et al., 2008). Autosomal-
dominant hyper-IgE syndrome (AD-HIES) is caused by 
heterozygous mutations in STAT3 (Holland et al., 2007; 
Minegishi et al., 2007; Casanova et al., 2012). These muta-
tions operate in a dominant-negative manner, effectively reduc-
ing the level of functional STAT3 by 75%. Loss-of-function 
mutations in STAT1 also underlie several immunodeficiency 
states, such as those characterized by selective susceptibility to 
infection with environmental mycobacteria and, depending 
on the nature of the mutation (i.e., dominant/recessive), some 
viruses (Boisson-Dupuis et al., 2012; Casanova et al., 2012). 
By examining these patients, we previously found that func-
tional STAT3 deficiency not only severely compromised the 
generation of memory (i.e., CD27+) B cells in vivo, but pre-
vented IL-10– and IL-21–mediated induction of PRDM1 
(Blimp-1 [B lymphocyte induced maturation protein-1]) and 
XBP1 (X-box binding protein 1) in naive B cells and their sub-
sequent differentiation to the PC lineage in vitro. However, 
STAT3 mutant (STAT3MUT) naive B cells could still acquire 
expression of AICDA (activation-induced cytidine deaminase) 
and undergo IL-21–induced isotype switching in vitro. In 
contrast, STAT1 was dispensable for human B cell differenti-
ation in vivo and in vitro (Avery et al., 2010).
These findings led us to investigate further the role of 
STATs in governing human B cell differentiation. We have 
now discovered that the small number of memory B cells 
generated in STAT3-deficient patients are unaffected by these 
mutations; thus, they are capable of differentiating into Ab- 
secreting cells in response to STAT3-actvating cytokines as 
efficiently as normal memory cells. These findings demon-
strate that the threshold of STAT3 activation required for 
B cell differentiation is significantly lower in memory compared 
with naive cells. Consequently, limiting amounts of functional 
STAT3 are sufficient to mediate memory, but not naive, B cell 
differentiation, thereby revealing an intrinsic difference in the 
requirements for activating naive versus memory B cells. The 
memory B cell deficiency in AD-HIES patients likely contrib-
utes to impaired Ag-specific Ab responses characteristic of these 
individuals. Thus, by targeting the residual population of STAT3-
deficient memory B cells to respond to IL-21, it may be possible 
to improve humoral immunity in AD-HIES.
Long-lived immunological memory is mediated by the com-
bined effects of long-lived plasma cells (PCs) and memory 
B cells generated in response to T-dependent antigens (Ags) 
and underlies the success of most currently available vaccines 
(Ahmed and Gray, 1996; Rajewsky, 1996; Tangye and 
Tarlinton, 2009; Goodnow et al., 2010). PCs reside in survival 
niches in bone marrow and secondary lymphoid tissues and 
constantly produce high titers of neutralizing antibodies 
(Abs; Tangye and Tarlinton, 2009; Tangye, 2011). In contrast, 
memory B cells recirculate throughout peripheral blood, 
secondary lymphoid tissues, and bone marrow. Upon reexposure 
to Ag, they can proliferate and differentiate into Ab-secreting 
plasmablasts more rapidly than naive cells, thereby replen-
ishing the PC pool and simultaneously expanding the memory 
cell population (Ahmed and Gray, 1996; Rajewsky, 1996; 
Tangye and Tarlinton, 2009).
Analysis of gene-targeted mice and humans with mono-
genic primary immunodeficiencies has identified some of the 
molecular requirements for memory B cell generation. Thus, 
mutations in B cell–intrinsic genes (CD19/CD81, CD40, 
IKBKG, DOCK8, and IL2RG) or genes expressed by CD4+ 
T helper cells (CD40LG, ICOS, and SH2D1A [SAP]) all re-
sult in reductions in the frequencies of memory B cells and 
associated deficiencies in total serum Ig levels or Ag-specific 
Ab (Tangye and Tarlinton, 2009; Recher et al., 2011; Jabara 
et al., 2012; Tangye et al., 2012). We also have some under-
standing of the mechanisms that enable memory B cells to 
respond more rapidly and vigorously than naive cells to cog-
nate Ag. First, memory B cells are recruited into division sig-
nificantly earlier and undergo more rounds of division than 
naive cells (Bernasconi et al., 2002; Tangye et al., 2003a,b; 
Macallan et al., 2005). Second, memory B cells have higher 
expression of cell surface receptors, TLRs (TLR7/9/10), 
CD21, CD27, and TACI, that could enable them to respond 
more efficiently to co-stimulatory signals (Tangye et al., 1998; 
Bernasconi et al., 2002, 2003; Darce et al., 2007; Good et al., 
2009). Third, memory B cells express heightened levels of 
CD80 and CD86 (Liu et al., 1995; Tangye et al., 1998; Ellyard 
et al., 2004; Good et al., 2009), which facilitate soliciting help 
from T helper cells. Fourth, memory B cells express lower 
levels of genes that restrict the entry of naive B cells into 
division, limiting their activation (Good and Tangye, 2007; 
Horikawa et al., 2007). Lastly, distinct signaling pathways 
downstream of the B cell receptor expressed by naive (i.e., 
IgM) or memory (IgG) cells have been identified that prefer-
entially promote responsiveness of memory cells (Martin and 
Goodnow, 2002; Engels et al., 2009; Davey and Pierce, 2012). 
However, the requirements for cytokine-mediated regulation 
of naive and memory B cells remain to be determined.
Human B cell differentiation is regulated by the actions of 
numerous cytokines, with IL-10 and IL-21, produced by 
T follicular helper cells (Tfh cells), being key factors in pro-
moting proliferation, isotype switching, PC differentiation, 
and secretion of most Ig isotypes by not only naive B cells, 
but also memory B cells, including both IgM+ and isotype-
switched subsets (Banchereau et al., 1994; Arpin et al., 1997; 
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significantly down-regulated on normal memory B cells (Fig. 1, 
A and C; and Table 1). Interestingly, CD23 expression was 
dysregulated on STAT3MUT B cells inasmuch as its level ex-
ceeded that on normal naive B cells by >10-fold, whereas it 
was detected on a substantial proportion of STAT3MUT mem-
ory B cells (Fig. 1, B and C; and Table 1).
We also determined expression of Ig isotypes by CD27 
and CD27+ B cells from normal and STAT3-deficient indi-
viduals. Approximately 90% of CD27 B cells and 40–
50% of CD27+ B cells from normal and STAT3-deficient 
individuals expressed IgM and IgD, with the remaining 
memory B cells expressing predominantly IgG or IgA (Table 1). 
Although the proportion of STAT3MUT CD27+ B cells that 
expressed IgG was greater than that observed for normal 
CD27+ B cells (Table 1), the distribution of IgG subclasses 
within the CD27 and CD27+ B cell subsets was compara-
ble, with IgG1 being preferentially expressed by both CD27 
and CD27+ normal and STAT3MUT B cells (Table 1). Fur-
thermore, we did not detect an enrichment of B1 cells, 
based on cells with a CD20+CD43+CD27+ phenotype, in 
STAT3MUT individuals compared with healthy donors (not 
depicted). Collectively, these findings confirm there is a sig-
nificant contraction of the memory B cell compartment in 
AD-HIES and provide evidence that the small population of 
CD27+ B cells in STAT3MUT individuals are indeed memory 
B cells (Table 1).
IL-2 activates STAT, STAT3, and STAT5  
in naive and memory B cells
IL-21 has been reported to activate multiple signaling path-
ways in different cell types (Asao et al., 2001; Zeng et al., 
2007; Diehl et al., 2008). To determine whether different 
subsets of human B cells used similar signaling pathways 
downstream of the IL-21 receptor, we examined phosphory-
lation of STAT proteins in normal naive, IgM memory, and 
RESULTS
STAT3MUT CD27+ B cells phenotypically resemble  
normal memory B cells
The population of circulating CD27+ memory B cells is signif-
icantly reduced in STAT3-deficient patients (n = 27) com-
pared with normal donors (Table 1; Avery et al., 2010). In 
contrast, the frequency of memory B cells in STAT1-deficient 
individuals is comparable with normal donors (i.e., 24.4 ± 
6.1%; n = 9). Although it is generally accepted that CD27 is 
expressed on human memory B cells (Tangye and Tarlinton, 
2009), recent studies have suggested that B1 cells (Griffin et al., 
2011) and some bone marrow progenitor B cells (Nilsson 
et al., 2005) are also CD27+. Conversely, a small proportion of 
memory B cells lack CD27 (Tangye and Tarlinton, 2009). 
Thus, it was important to establish the nature of the residual 
population of CD27+ B cells in STAT3MUT patients.
The size and granularity of CD27 and CD27+ B cells 
were determined by flow cytometry. This demonstrated that 
CD27+ B cells from both normal donors and STAT3MUT  
patients were significantly larger and more granular than cor-
responding CD27 B cells. However, these morphological 
features were not significantly different between cells from 
normal donors and STAT3MUT patients (Fig. 1, A–C).
We next examined a series of surface receptors that are 
differentially expressed by human naive and memory B cells 
(Liu et al., 1995; Tangye et al., 1998; Ellyard et al., 2004; 
Good et al., 2009). CD24, CD80, CD95, and TACI were 
significantly higher on CD27+ B cells from normal donors 
than on corresponding CD27 B cells (Fig. 1, A and C). 
CD86 also tended to be higher on normal CD27+ versus 
CD27 B cells (Fig. 1, A and C). The same pattern was seen 
for samples from STAT3MUT patients, with CD80, CD86, 
CD95, and TACI being significantly higher on CD27+ than 
on CD27 B cells (Fig. 1, B and C). In contrast to these 
molecules, CD23 is present on normal naive B cells but is 
Table . Characteristics of CD27 and CD27+ B cells in STAT3-deficient individuals
Parameter CD27 B cells CD27+ B cells
Normal STAT3MUT Normal STAT3MUT
% Cells 75.2 ± 2.7 94.9 ± 0.77 24.8 ± 2.7 5.1 ± 0.77
% IgM+ 87.0 ± 2.2 90.0 ± 2.0 47 ± 3.8 48 ± 3.1
% IgD+ 88.0 ± 1.9 93.0 ± 1.8 41 ± 2.2 45 ± 2.0
% IgG+ 3.2 ± 0.45 1.6 ± 0.6a 25 ± 2.1 32 ± 2.8a
% IgG1+ (% total IgG+ cells) 2.3 ± 1.0 (62.1) 0.63 ± 0.24 (40.1) 11 ± 1.7 (51.4) 22 ± 2.8 (72.7)b
% IgG2+ (% total IgG+ cells) 0.72 ± 0.14 (19.4) 0.54 ± 0.1 (34.4) 6.7 ± 2.1 (31.3) 3.9 ± 0.9 (12.9)
% IgG3+ (% total IgG+ cells) 0.62 ± 0.15 (16.7) 0.36 ± 0.12 (22.9) 3.6 ± 0.9 (16.8) 4.1 ± 1.1 (13.5)
% IgG4+ (% total IgG+ cells) 0.065 ± 0.02 (1.8) 0.04 ± 0.014 (2.5) 0.11 ± 0.04 (0.5) 0.27 ± 0.08 (0.9)
% IgA+ 1.2 ± 0.2 0.64 ± 0.15a 17 ± 1.2 8.6 ± 1.1c
% CD23+ 62.0 ± 3.9 86.0 ± 3.7c 18 ± 3.9 46 ± 4.7c
Values represent percentage (or absolute number for CD4+CXCR5+ T cells) of cells expressing the indicated surface molecule; each value represents the mean ± SEM; normal 
donors: n = 8–24; STAT3 patients: n = 9–27. P-values were determined by Student’s t test, comparing normal with STAT3MUT B cells.
aP < 0.05.
bP < 0.01.
cP < 0.001.
 o
n
 N
ovem
ber 11, 2013
jem.rupress.org
D
ow
nloaded from
 
Published November 11, 2013
 of 5 Differential function of STAT3 in human B cells | Deenick et al.
differences between naive and memory B cells in their require-
ment for STAT3 function to respond to cytokines such as 
IL-10 and IL-21, which are well known for their abilities to 
induce human B cell differentiation (Banchereau et al., 1994; 
Arpin et al., 1997; Pène et al., 2004; Ettinger et al., 2005; 
Bryant et al., 2007; Avery et al., 2008a,b).
Naive and memory B cells isolated from normal donors 
or STAT3MUT or STAT1MUT patients were cultured with 
CD40L alone or together with IL-21, and Ig secretion was 
determined after 10–12 d. Because of the limited numbers of 
memory cells recovered from STAT3MUT patients, we could 
only culture 5,000 sorted B cells/well. Under these condi-
tions, IL-21 potently promoted secretion of IgM and induced 
production of IgG and IgA by normal and STAT1MUT naive 
B cells (Fig. 3 A and Table 2). IL-21 substantially increased 
production of IgM, IgG, and IgA by CD40L-stimulated 
memory B cells from normal donors and STAT1-deficient 
individuals; however, the response of STAT1MUT memory 
B cells was significantly less (approximately fourfold) than 
that of normal memory cells (Fig. 3 B and Table 2). Ig secre-
tion by STAT3MUT naive B cells in response to IL-21 was 
30-fold less than normal naive cells (Fig. 3 A and Table 2; 
P < 0.001). In distinct contrast, Ig secretion by IL-21–stimu-
lated STAT3MUT memory B cells (either total memory cells 
[Fig. 3 B and Table 2] or IgM+ and switched subsets [not de-
picted]) was largely comparable with normal memory B cells, 
isotype-switched memory B cells in response to IL-21. Phos-
phorylation of STAT1, STAT3, and STAT5 was greater in 
naive B cells than in memory B cells; however, STAT1 and 
STAT3 were both clearly activated by IL-21 in both IgM- 
expressing and Ig-switched memory B cell subsets (Fig. 2, 
A and B). In contrast to these STATs, IL-21 had minimal, if 
any, effect on phosphorylation of STAT4 or STAT6 (Fig. 2 A). 
Although IL-21 has been reported to activate ERK and AKT 
(Zeng et al., 2007), we observed no ERK or AKT phosphor-
ylation in response to IL-21 in naive or memory B cells 
(Fig. 2, C and D). These results demonstrate that IL-21R sig-
naling activates similar pathways in human naive and memory 
B cells, predominantly STAT1, STAT3, and STAT5.
Mutations in STAT3 impair the response of naive, but not 
memory, B cells to the stimulatory effects of IL-0 and IL-2
STAT3 is required for some, but not all, aspects of naive B cell 
differentiation. For instance, isotype switching was intact in 
STAT3MUT B cells, as indicated by the detection of circulating 
IgG+ and IgA+ B cells in AD-HIES patients ex vivo (Table 1) 
and the ability of their naive B cells to up-regulate AICDA and 
switch to IgG in response to IL-21 in vitro (Avery et al., 2010). 
Consistent with intact AICDA expression in STAT3MUT naive 
B cells in vitro, somatic hypermutation was comparable in nor-
mal and STAT3MUT memory B cells (Avery et al., 2010). 
These observations lead us to question whether there were also 
Figure . Morphology and phenotype of CD27+ B cells in STAT3MUT individuals resemble normal memory B cells. (A–C) PBMCs from normal 
donors and patients with AD-HIES caused by mutations in STAT3 were stained with mAbs specific for CD20, CD27, and CD23, CD24, CD80, CD86, CD95, or 
TACI. The forward scatter (FSC) and 90° light/side scatter (SSC) and surface expression of the indicated molecules on CD27 (naive) and CD27+ (memory) 
B cells were determined. The histograms in A and B are from a representative normal donor and patient, respectively, whereas the graphs in C depict the 
geometric mean fluorescence intensity (MFI) of each of the indicated cellular features for CD27 naive (N) and CD27+ memory (M) B cells from 3–12 
normal donors and STAT3MUT patients. Each value represents an individual donor or patient; the horizontal lines correspond to the mean. Because of the 
large difference in the level of expression of CD23 on normal versus STAT3MUT naive and memory B cells, individual graphs are depicted for normal and 
patient B cell subsets. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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B cells to CD40L together with IL-10 or IL-21 (Fig. 3 B, 
Table 2, and not depicted), these cells also exhibited normal 
responses to stimulation with CD40L/CpG (Fig. 3 D) or 
CD40L/IL-4 (Fig. 3, E and F). Because many facets of lym-
phocyte differentiation are linked to cell division (Hodgkin 
et al., 1996; Deenick et al., 1999; Tangye et al., 2003a,b; 
Avery et al., 2005, 2008a), we also assessed the proliferative 
potential of STAT3MUT naive and memory B cells. IL-21 en-
hanced proliferation of both normal and STAT3MUT naive 
B cells over that induced by CD40L alone, yet the response of 
STAT3MUT naive B cells was approximately threefold less than 
that of normal B cells (Fig. 3 G). Consistent with the differen-
tial dependency on STAT3 function for IL-21–induced Ig se-
cretion by naive versus memory B cells, STAT3MUT memory 
with the only significant difference (less than twofold) being 
noted for the levels of IgM secreted by normal versus STAT-
3MUT memory B cells (Table 2). Furthermore, both IgM 
memory (i.e., IgM+CD27+) and switched (IgM/DCD27+) 
memory cells from STAT3-deficient patients could respond 
to the stimulatory effects of IL-10 (not depicted).
The inability of STAT3MUT naive B cells to respond to 
IL-21 did not reflect a general impairment in differentiation 
because these cells produced IgM after stimulation with 
CD40L plus CpG (Fig. 3 C) and up-regulated expression of 
AICDA (Fig. 3 E) and Ig  germline transcripts, a precursor 
to producing mature IgE (Geha et al., 2003), in response to 
CD40L/IL-4 (Fig. 3 F) as efficiently as normal naive B cells. 
Consistent with the intact response of STAT3MUT memory 
Figure 2. IL-2 induces activation of STAT, STAT3, and STAT5 in human naive and memory B cells. Human naive, IgM memory and isotype-
switched memory, or total memory, B cells were sort-purified from normal donor spleens. (A) These B cell subsets were cultured for 18 h with anti-Ig, 
rested, and then cultured in the absence (red histograms) or presence (blue histograms) of IL-21 for 30 min. Phosphorylation of STAT1, STAT3, STAT4, 
STAT5, and STAT6 was determined by intracellular staining. Histograms on the left show representative staining in naive and memory B cells. Right panels 
plot increase in mean fluorescence intensity of pSTATs in naive, IgM memory, and isotype-switched memory B cells cultured with IL-21; response of un-
stimulated cells were normalized to a value of 1.0. These values represent the mean ± SEM of two independent experiments using B cells from different 
donor spleens. Identical results were obtained when the B cell subsets were prestimulated with CD40L/anti-Ig. (B–D) Human B cell subsets were cultured 
for 18 h with anti-Ig, rested, and then left unstimulated or stimulated with IL-21 or anti-Ig for 15–30 min. Cells lysates were prepared and subjected to 
SDS-PAGE and Western blotting to detect phosphorylated or total STAT3 (B), phosphorylated or total ERK (C), or phosphorylated AKT or 14.3.3 as a load-
ing control (D). B–D are representative of three to four similar experiments.
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B cells proliferated to a similar extent as normal memory 
B cells in response to IL-21 (Fig. 3 H). Not surprisingly, 
CD40L/CpG induced comparable proliferation in STAT3-
sufficient and -deficient naive and memory B cells (Fig. 3, 
G and H). Thus, impaired proliferation of naive STAT3MUT 
B cells to IL-21 correlates with poor differentiation of these 
cells to plasmablasts under these culture conditions. How-
ever, naive STAT3MUT B cells do undergo some proliferation 
to IL-21 (Fig. 3 G; Avery et al., 2010), indicating that the 
block in differentiation is not simply caused by STAT3 mu-
tations abrogating cell division.
The memory cell pool in STAT3-deficient individuals 
contains Ag-specific B cells
Although the total levels of Ig produced by STAT3MUT mem-
ory B cells in response to STAT3 cytokines were normal, it 
was unknown whether these B cells could contribute to an 
Ag-specific Ab response. To address this, we quantified the 
relative amounts of antitetanus IgG produced by B cells from 
normal donors or STAT3MUT or STAT1MUT patients after 
in vitro culture with CD40L/IL-21. As expected, the levels of 
antitetanus IgG produced by normal naive B cells were very 
low/undetectable, whereas memory cells from most normal 
donors produced significantly higher amounts of tetanus- 
specific IgG (Fig. 3 I). Importantly, STAT3MUT memory B cells 
from all patients tested produced significantly higher amounts 
of tetanus-specific IgG than normal naive B cells (Fig. 3 I). 
Memory B cells from some STAT1MUT patients exhibited a 
lower response than others, but in general this exceeded that of 
normal naive B cells and, on average, approximated that of 
normal and STAT3MUT memory B cells (Fig. 3 I). We also 
assessed production of antitetanus IgG in cultures of total 
PBMCs from normal donors and STAT3MUT individuals that 
had been stimulated with CD40L and IL-21. On average, 
normal PBMCs produced approximately threefold higher lev-
els of antitetanus IgG than did STAT3MUT PBMCs (Fig. 3 J). 
However, there are several caveats to screening PBMCs, rather 
than purified B cells, for the production of Ag-specific Ab. 
Figure 3. STAT3-deficient memory B cells differentiate into Ab-
secreting cells in response to IL-2. (A–D) Naive (CD20+CD10CD27IgG) 
and memory (CD20+CD10-CD27+) B cells were sort-purified from normal 
donors (A and B, n = 16; C and D, n = 7), STAT3MUT patients (A and B,  
n = 8; C and D, n = 7), or STAT1MUT patients (n = 6), and then cultured with 
CD40L alone or together with IL-21 (A and B) or CpG (C and D). The levels 
of secreted IgM, IgG, and IgA were determined by ELISA after 10–12 d. The 
columns represent the mean ± SEM of experiments performed using naive 
B cells from 7–16 normal donors, 7–8 STAT3MUT patients, or 6 STAT1MUT 
patients. (E and F) Naive and memory B cells were sort-purified from nor-
mal donors or STAT3MUT patients and then cultured with CD40L alone or 
together with IL-4. Expression of AICDA (E) and Ig  germline transcript 
(GLT; F) was determined by qPCR and PCR, respectively. The graphs in E 
represent the mean ± SEM of three experiments using B cells from different 
donors or patients. The gel depicted in F is representative of experiments 
performed using B cells from two to three different donors or patients.  
(G and H) Naive and memory B cells were sort-purified from a single  
normal donor or STAT3MUT patient and then cultured with CD40L alone or 
together with IL-21 or CpG. Proliferation was assessed after 5 d by deter-
mining incorporation of [3H]thymidine during the last 18 h of culture.  
The graphs are the mean ± SEM of replicate cultures of naive or memory 
B cells from one normal donor or one STAT3MUT patient. The annotated 
values indicate the fold increase in proliferation of normal or STAT3MUT 
naive or memory B cells cultured with CD40L/IL-21 or CD40L/CpG over 
that induced by CD40L alone. (I and J) Normal naive (N) or normal, STAT3MUT, 
or STAT1MUT memory (M) B cells (n = 6; I) or total PBMCs from normal  
donors or STAT3MUT patients (n = 4; J) were cultured with CD40L and IL-21 
for 10–12 d. The levels of antitetanus IgG in culture supernatants were 
determined by ELISA using immobilized tetanus toxoid as solid phase Ag. 
Each symbol represents the response of B cells from an individual control 
or patient; the horizontal bars represent means. ns, no significant;  
*, P < 0.05; **, P < 0.01.
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effect on naive B cell differentiation, in terms of the fre-
quency of plasmablasts and Ig secretion, after 4 d of culture 
(Fig. 4, A–C); however, a substantial proportion of memory 
B cells had differentiated to become Ig-secreting plasmablasts 
at this time (Fig. 4, D–F). The rate of plasmablast formation 
from naive and memory B cells increased after 5.5 d and 
tended to plateau or decline at later times (7 d; Fig. 4, B and E). 
Co-incident with this was a dramatic increase in Ig secretion 
by both naive and memory B cells between 4 and 5.5 d of 
in vitro culture (Fig. 4, C and F). The rate of formation of 
plasmablasts and Ig secretion by IL-21–stimulated naive and 
memory B cells was not affected by STAT1 mutations (Fig. 4). 
Collectively, these results suggested that STAT1MUT memory 
B cells could initially generate normal numbers of functional 
plasmablasts. However, in contrast to this normal rate of dif-
ferentiation of STAT1MUT memory B cells between days 4 
and 7 of culture (Fig. 4, D–F), Ig secretion by these cells after 
11 d of culture was consistently less than that by normal 
memory B cells (Fig. 3 B and Table 2). Thus, STAT1 may 
play a role in sustaining Ig secretion by differentiated memory 
B cells.
Commitment of memory B cells to the PC lineage  
is unaffected by mutations in STAT or STAT3
The differentiation of human and mouse B cells into PCs is 
regulated by the coordinated actions of several transcription 
factors. PAX5 is down-regulated in activated B cells, thereby 
relieving PAX5-mediated repression of Blimp-1, resulting in 
Blimp-1 expression. Although Blimp-1 is not required for 
initial commitment to the PC lineage, it is indispensable for the 
generation of terminally differentiated PCs. Other transcrip-
tion factors, XBP-1 and IRF4 (interferon-induced regulatory 
First, there is substantial variability in the frequencies of B cells 
within the population of all PBMCs, as well as in the proportion 
of B cells that are memory cells. Indeed, there is a strong cor-
relation between the frequency of memory B cells and produc-
tion of antitetanus IgG in vitro (not depicted). Second, the 
addition of CD40L to cultures of PBMCs will activate myeloid 
cells (monocytes, macrophages, and DCs) to secrete molecules 
such as BAFF and APRIL (Litinskiy et al., 2002; Craxton 
et al., 2003), which can preferentially promote differentiation 
and Ig secretion by human memory B cells presumably in a 
STAT3-independent manner (Avery et al., 2003). Even taking 
these into account, it is clear that STAT3-deficient individuals 
are capable of generating Ag-specific Ab responses and that 
these Ag-specific cells reside within the residual subset of 
CD27+ B cells. This further substantiates that these cells are 
indeed memory B cells and are likely to contribute to Ag- 
specific Ab responses in vivo.
STAT deficiency does not affect the early differentiation 
of memory B cells into Ig-secreting plasmablasts
The accumulated levels of Ig secreted by STAT1MUT mem-
ory B cells were 2.5–5-fold less than those by normal mem-
ory cells (Fig. 3 B and Table 2). To determine whether this 
reflected a quantitative defect in generating Ab-secreting cells 
from STAT1MUT memory B cells, we performed kinetic 
analyses of plasmablast formation and Ig secretion by normal 
and STAT1MUT naive and memory B cells that had been 
stimulated with CD40L alone or together with IL-21. CD40L 
alone resulted in <0.5% of normal and STAT1MUT naive B cells 
and 1–3% of memory B cells acquiring a CD38hiCD27hi 
phenotype, which corresponds to plasmablasts (Fig. 4, A, B, 
D, and E; Avery et al., 2005). Addition of IL-21 had minimal 
Table 2. Ig secretion by IL-21–stimulated normal, STAT3MUT, and STAT1MUT naive and memory B cells
Cell type and 
culture
Ig secretion
IgM IgG IgA
Normal STAT3MUT STAT1MUT Normal STAT3MUT STAT1MUT Normal STAT3MUT STAT1MUT
ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml
Naive B cells
CD40L 2.0 ± 1.0 5.0 ± 2.4a <0. 1a <1 <1a <1a <1 <1a <1a
+IL-21 14,640 ± 
2,021
444 ± 177d 10,801 ± 
3,183a
267 ± 80 7.3 ± 2.7b 86 ± 40a 365 ± 106 4.6 ± 2.6b 174 ± 40a
Memory B cells
CD40L 166 ± 51 100 ± 25a 2.5 ± 2.5a 6.1 ± 1.4 11.8 ± 4.7a 0.2 ± 0.14a 21.3 ± 6.1 26.2 ± 10.6a <1a
+IL-21 29,389 ± 
4,107
15,214 ± 
1,905b
7,396 ± 3,097d 4,202 ± 
1,122
5,651 ± 
1,743a
953 ± 195a 25,208 ± 
4,134
13,330 ± 
4,027a
4,265 ± 989c
Naive and memory B cells were sort-purified from normal healthy donors (n = 17), STAT3MUT patients (n = 8), or STAT1MUT patients (n = 6) and then cultured with CD40L alone 
or together with IL-21. The levels of secreted IgM, IgG, and IgA were determined by ELISA after 10–12 d. The values represent the mean ± SEM from the indicated number of 
donors/patients and correspond to the data depicted in Fig. 3 (A and B). Statistical analyses were performed using one-way ANOVA; differences are indicated for normal 
donors compared with STAT3MUT or STAT1MUT B cells.
aNot significant.
bP < 0.01.
cP < 0.001.
dP < 0.0001.
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differences in the behavior of naive and memory cells. Al-
though naive STAT3MUT B cells down-regulated PAX5 in re-
sponse to IL-21, they failed to up-regulate PRDM1 and XBP1 
(Fig. 5 A). In stark contrast, IL-21–mediated induction of 
PRDM1, XBP1, and IRF4 in STAT3MUT memory B cells was 
intact (Fig. 5 B), mirroring the ability of these cells to secrete 
large amounts of Ig in response to IL-21 (Fig. 3 B). Induction 
of AICDA in STAT3MUT naive B cells by IL-21 was compara-
ble with normal and STAT1MUT naive B cells (Fig. 5 A), fur-
ther demonstrating that STAT3MUT naive B cells can respond 
to IL-21 under the culture conditions used here. In contrast to 
naive B cells, IL-21 reduced AICDA expression in memory 
B cells from all individuals compared with stimulation with 
CD40L alone (Fig. 5 B). This is probably a result of memory 
B cells expressing much higher levels of PRDM1 (Fig. 5 B), 
which directly represses AICDA (Nutt et al., 2011). Thus, dif-
ferentiation of naive and memory B cells into Ab-secreting 
cells, as determined both at the cellular and molecular level, 
exhibit distinct sensitivity to mutations in STAT3.
Memory cells exhibit greater sensitivity to the stimulatory 
effects of STAT3-activating cytokines IL-2 and IL-0
One possible explanation for this differential susceptibility to 
mutations in STAT3 would be that in memory B cells IL-21 
activates an alternate STAT3-independent signaling pathway. 
However, we observed little activation of pathways other 
than STAT1 and STAT3 in memory B cells (Fig. 2). An alter-
native possibility was that memory B cells expressed higher levels 
of STAT3 or were enriched for expression of the wild-type 
factor-4), are also involved in PC differentiation (Nutt et al., 
2011). A key mechanism by which IL-21 mediates differen-
tiation of naive B cells into PCs is by modulating expression 
of these transcription factors. Thus, naive B cells lose PAX5 
and acquire Blimp-1 and XBP-1 in response to IL-21 in vitro 
(Ettinger et al., 2005; Bryant et al., 2007).
Our finding that STAT3MUT memory, but not naive, 
B cells were capable of secreting near-normal levels of Ig in 
response to IL-21 (Fig. 3 and Table 2) led us to investigate 
transcriptional changes in normal and STAT3MUT naive and 
memory B cells after stimulation with IL-21. We also exam-
ined STAT1MUT naive and memory B cells as the latter had 
some defects in secreting normal levels of Ig (Fig. 3 and Table 2). 
Addition of IL-21 to cultures of B cells from normal donors 
resulted in the down-regulation of PAX5 and up-regulation 
of PRDM1 and XBP1 in naive and memory B cells (Fig. 5, 
A and B). PRDM1 and XBP1 were substantially higher, and 
PAX5 much lower, in memory versus naive cells (Fig. 5, 
A and B). Furthermore, although IL-21 had no detectable 
effect on IRF4 expression in normal naive B cells (Fig. 5 A), 
it induced an approximately threefold increase in IRF4 in 
normal memory B cells (Fig. 5 B). These differences likely 
contribute to memory B cells secreting 10–20-fold more Ig 
than naive cells (Figs. 3 and 4 and Table 2).
STAT1MUT naive and memory B cells modulated expres-
sion of PAX5, PRDM1, XBP1, and IRF4 in a manner indis-
tinguishable from normal B cells (Fig. 5, A and B), consistent 
with normal Ig secretion during short-term cultures 
(Fig. 4, C and F). However, STAT3MUT B cells revealed marked 
Figure . STAT mutations do not affect the generation of plasmablasts but impair sustained Ig secretion. (A–F) Naive (A–C) and memory  
(D–F) B cells were sort-purified from normal donors or STAT1MUT patients and then cultured (25 × 103/well/100 µl) with CD40L alone (open symbols in  
B and E) or together with IL-21 (closed symbols in B and E). The generation of plasmablasts, defined as cells acquiring a CD38hiCD27hi phenotype (A, B, D, 
and E), as well as secretion of IgM, IgG, and IgA (C and F), was determined after 4, 5.5, and 7 d. The contour plots (A and D) are representative of plasma-
blasts detected after 5 d of culture. The graphs depicting Ig secretion are from cultures of CD40L/IL-21–stimulated B cells. The values represent the mean 
(±SEM for B, C, E, and F) of experiments using cells from two normal donors and two STAT1MUT patients. Similar results were obtained in a second inde-
pendent experiment.
 o
n
 N
ovem
ber 11, 2013
jem.rupress.org
D
ow
nloaded from
 
Published November 11, 2013
JEM 
Article
 of 5
(i.e., 10 ng/ml IL-21 and 100 U/ml IL-10) were at least five 
times higher than those required for induction in memory 
B cells (i.e., 2 ng/ml IL-21 and 20 U/ml IL-10). Further-
more, these cytokines induced PRDM1 in memory B cells at 
levels that exceeded those in naive B cells by two- to five-
fold (Fig. 6, A and B, left). Induction of XBP1 followed a 
similar pattern, with expression being detected in memory 
B cells at much reduced cytokine concentrations than in 
naive B cells and memory B cells expressing substantially 
more XBP1 than naive B cells (Fig. 6, A and B, right). Col-
lectively, these results demonstrate that memory B cells have 
greater sensitivity to the stimulatory effects of these STAT3-
activating cytokines, especially when present at limiting con-
centrations. Thus, it is likely that the small percentage of 
wild-type STAT3 dimers that can form in STAT3MUT mem-
ory B cells are sufficient to integrate signals provided by 
IL-10 and IL-21 to facilitate the differentiation of memory 
B cells into Ig-secreting plasmablasts.
Loss-of-function mutations in IL2R abolishes  
responses of naive and memory B cells to IL-2
To establish that the differences in responses of naive and 
memory STAT3MUT B cells to IL-21 involved direct signal-
ing through the IL-21R, rather than interactions between 
IL-21 and a putative alternate receptor that may be expressed 
only on memory B cells and functions independently of 
STAT3 allele compared with naive B cells. Yet we found that 
naive and memory B cells from normal donors or AD-HIES 
patients expressed comparable levels of STAT3 both ex vivo 
and after in vitro culture (not depicted) and that the mutant 
allele still accounted for 50% of total STAT3 that was ex-
pressed by memory B cells (not depicted). A final explanation 
for the differential effects of STAT3 deficiency on the func-
tion of naive versus memory B cells derives from the hetero-
zygous nature of the STAT3 mutations and the fact that 
STATs exert their effect as dimers. This predicts that the mu-
tant allele acts in a dominant-negative manner, thereby in-
hibiting the function of up to 75% of STAT3 dimers and 
leaving only 25% intact (Holland et al., 2007; Minegishi 
et al., 2007). Thus, the differential sensitivity of naive and 
memory B cells to STAT3 mutations may reflect an increased 
responsiveness of memory cells to STAT3 action such that 
the residual wild-type STAT3 dimers in STAT3MUT mem-
ory, but not naive, B cells are sufficient to render these cells 
responsive to the effects of STAT3-activating cytokines. To 
test whether there are differences in the threshold of activa-
tion of naive and memory B cells, these B cell subsets were 
purified from normal donor spleens and cultured with CD40L 
and increasing concentrations of IL-21 or IL-10, and induc-
tion of expression of PRDM1 and XBP1 was determined after 
4 d. The concentrations of IL-21 (Fig. 6 A, left) and IL-10 
(Fig. 6 B, left) required to induce PRDM1 in naive B cells 
Figure 5. Induction of the PC transcriptional program is intact in IL-2–stimulated STAT3MUT memory B cells. (A and B) Naive 
(CD20+CD10CD27IgG; A) and memory (CD20+CD10CD27+; B) B cells were sort-purified from normal donor controls (Ctl; n = 10 [or 7 for AICDA]), 
STAT3MUT patients (n = 5), or STAT1MUT patients (n = 4) and then cultured with CD40L alone or together with IL-21 (+IL-21) for 5 d. Expression of PAX5, 
PRDM1, XBP1, IRF4, and AICDA was determined by qPCR. The columns represent the mean ± SEM of experiments performed using naive B cells from  
7–10 normal donors, 5 STAT3MUT patients, or 4 STAT1MUT patients. Levels of expression are relative to the amount of GAPDH. ns, not significant;  
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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mutations in IL21R (Fig. 7, D–F). Not surprisingly, CD40L-
stimulated IL-21RMUT memory B cells also failed to respond to 
the stimulatory effects of IL-21 (Fig. 7 E). IL-21RMUT naive 
B cells, though, are intrinsically functional, as indicated by in-
tact responses to IL-4 and IL-10 with respect to induction of 
AICDA (IL-4 and IL-10) and XBP1 (IL-4) and reduction in 
PAX5 (IL-10; Fig. 7 F). These findings demonstrate the speci-
ficity of the IL-21 used in our experiments and reveal that both 
naive and memory B cells absolutely require a functional 
IL-21R for their response to IL-21.
DISCUSSION
Naive and memory B cells play distinct roles during humoral 
immune responses. Thus, naive B cells activated after primary 
encounter with foreign Ag initially produce Ag-specific IgM 
and eventually yield B cells that produce IgG or IgA. In con-
trast, memory cells respond much more efficiently upon sub-
sequent exposure to such Ags, rapidly differentiating into 
Ab-secreting cells to produce substantially higher levels of 
protective Ig than naive cells (Ahmed and Gray, 1996; Rajewsky, 
1996; Tangye and Tarlinton, 2009). This increased efficacy 
of memory B cell activation is one mechanism underlying 
long-term protective immunological memory.
B cell differentiation into plasmablasts is regulated by the 
integration of signals provided by Ag, T cell help (CD40L), 
and cytokines. Signal transduction pathways activated by these 
ligands converge to activate key transcriptional regulators, 
such as Blimp-1, that mediate the commitment of activated 
B cells to a PC fate (Nutt et al., 2011). Cytokines important 
for human B cell differentiation include IL-10 and IL-21, 
which induce isotype switching, PC generation, and Ab se-
cretion from activated naive and memory B cells (Banchereau 
et al., 1994; Arpin et al., 1997; Pène et al., 2004; Ettinger 
et al., 2005; Bryant et al., 2007; Avery et al., 2008a). A com-
mon feature of these cytokines is their ability to activate simi-
lar signaling intermediates, such as STAT1 and STAT3. 
Remarkably, the effects of IL-10 or IL-21 on human naive 
B cells are abolished by heterozygous STAT3 mutations, yet 
are unaffected by mutations in STAT1 (Figs. 3–5; Avery et al., 
2010). These defects likely explain defective Ab responses and 
reduced numbers of memory B cells in AD-HIES (Leung 
et al., 1988; Sheerin and Buckley, 1991; Avery et al., 2010) and, 
conversely, intact humoral responses in STAT1-deficient pa-
tients (Boisson-Dupuis et al., 2012). Interestingly, mutations 
in IL21R recapitulated the impaired Ab responses to vaccines 
(Kotlarz et al., 2013) and memory B cell deficit (Fig. 7) ob-
served in AD-HIES, despite the ability of IL-21R–deficient 
B cells to respond to other growth and differentiation- 
inducing cytokines such as IL-4 or IL-10. In contrast, B cell 
responses in vivo appear intact in IL-10/IL-10R–deficient in-
dividuals (Kotlarz et al., 2012). Thus, STAT3, downstream of 
IL-21R, clearly plays a central role in establishing long-lived 
Ab-mediated immunity.
Our study revealed that STAT3 mutations do not affect 
memory B cell function, as STAT3MUT memory cells under-
went the molecular and cellular changes required for plasmablast 
STAT3, we examined the B cell compartment in recently 
identified individuals with loss-of-function mutations in 
IL21R (Kotlarz et al., 2013). Phenotypic analysis of three in-
dividuals revealed a marked deficiency in memory B cells 
that was comparable with that observed for STAT3MUT  
patients (Fig. 7 A and Table 1). Furthermore, in contrast to 
healthy donors, 95% of IL-21RMUT B cells were IgM+IgD+, 
revealing a deficiency in Ig isotype–switched cells (Fig. 7 B). 
We also quantified the proportion of memory B cells that 
expressed specific Ig isotypes and found that although 50% 
of memory B cells from normal donors had lost expression of 
IgD and IgM, >90% of IL-21RMUT memory B cells remained 
IgD+ (Fig. 7 C and not depicted). Consistent with this, <5% 
of IL-21RMUT memory B cells had undergone switching to 
express IgG or IgA, whereas the memory B cell pool of nor-
mal donors is comprised of 25% IgG+ and 20% IgA+ cells 
(Fig. 7 C). Thus, IL-21 signaling is indispensable for the gen-
eration of not only a normal pool of memory B cells but also 
the generation of isotype-switched effector B cells within the 
memory cell subset.
When naive B cells were isolated from normal donors and 
IL-21RMUT individuals and cultured in vitro, only B cells from 
normal donors responded to IL-21, as revealed by the genera-
tion of CD38hiCD27hi plasmablasts (Fig. 7 D), secretion of 
high levels of IgM, IgG, and IgA (Fig. 7 E), and down- 
regulation of PAX5 while concomitantly acquiring AICDA, 
PRDM1, and XBP1 expression (Fig. 7 F). All of these readouts 
of naive B cell differentiation were abolished by loss-of-function 
Figure . Memory B cells exhibit greater sensitivity to the differ-
entiation-inducing effects of STAT3-activating cytokines IL-2 and 
IL-0. (A and B) Naive and memory B cells were sort-purified from nor-
mal donor spleens and then cultured with CD40L alone or with increasing 
concentrations of IL-21 (A) or IL-10 (B). After 4 d, expression of PRDM1 
and XBP1 was determined by qPCR. The values are presented as the per-
centage of the maximum response, defined as the levels of expression 
induced in memory B cells by the highest dose of IL-21 tested (50 ng/ml). 
The data represent the mean ± SEM of experiments using naive and 
memory B cells from three different normal donor spleens.
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memory B cells to STAT3 cytokines. First, these cytokines 
may activate signaling pathways in memory B cells distinct 
from naive cells, thereby allowing memory cells to respond 
independently of STAT3, unlike naive B cells. This is un-
likely as we detected comparable activation of STATs, yet 
little activation of Erk and Akt in IL-21-stimulated naive and 
memory B cells. Second, STAT3 may be differentially ex-
pressed by naive and memory B cells; however, this was also 
differentiation in response to IL-10 or IL-21. Importantly, 
although memory cells are numerically deficient in AD-HIES 
patients, they produced normal levels of Ag-specific IgG 
in vitro on a per cell basis, inferring that STAT3MUT memory 
B cells would be functional in vivo. This explains the vari-
ability in impairment in humoral immunity in AD-HIES pa-
tients (Sheerin and Buckley, 1991; Avery et al., 2010). There 
are several explanations for the normal response of STAT3MUT 
Figure 7. Loss-of-function mutation in IL2R abolishes  
B cell responses to IL-2. (A and B) PBMCs from age-matched 
normal donors and three patients with loss-of-function muta-
tions in IL21R were labeled with mAb against CD20, CD10, 
CD27, IgM, IgD, IgG, and IgA. (A) Memory B cells were quantified 
based on the frequency of CD20+ B cells that were CD10CD27+. 
(B and C) The percentages of total B cells in normal donors or  
IL-21R–deficient patients that coexpressed IgM and IgD (B) and of 
memory (i.e., CD27+) B cells from normal donors and IL-21RMUT 
patients that expressed IgD, IgG, or IgA (C) were determined.  
**, P < 0.01. Each symbol in A and B represents an individual 
normal donor or IL-21RMUT patient; the horizontal bars represent 
means. The values in C represent the mean percentage ± SEM of 
memory B cells from four normal donors or three IL-21RMUT 
patients that express IgD, IgG, or IgA. (D–F) Naive or memory  
B cells sort-purified from normal donors or IL-21R1MUT patients 
were cultured with CD40L alone or CD40L/IL-21 (D and E) or 
CD40L/IL-4, CD40L/IL-10, or CD40L/IL-21 (F). After 5 d, the per-
centage of plasmablasts (i.e., CD38hiCD27hi) generated (D) and 
expression of PAX5, AICDA, PRDM1, and XBP1 by cultured naive 
B cells (F) were determined by flow cytometry or qPCR. The val-
ues in D represent the mean (±SEM) percentage of naive B cells 
that acquired a plasmablast phenotype in response to CD40L/IL-
21 in experiments using naive B cells from three different nor-
mal donors or one IL-21RMUT patient. In the absence of IL-21 
<0.5% plasmablasts were detected in these cultures. (E) The 
levels of secreted IgM, IgG, and IgA by naive and memory B cells 
from normal donors (ND) or IL-21RMUT patients (Pt) in response 
to stimulation with CD40L/IL-21 were determined by ELISA after 
10 d. The amounts of Ig secreted by IL21RMUT memory B cells in 
response to CD40L/IL-21 did not differ from those induced by 
CD40L alone (not depicted). These data are from one of three 
experiments using naive B cells from five different healthy con-
trols or two unrelated IL-21RMUT patients. The values in F repre-
sent the mean ± SEM from experiments using two to five 
different healthy controls or of three experiments using cells 
from two unrelated IL-21RMUT patients. The horizontal black lines 
on the graphs in F indicate a value of 1.0, which corresponds to 
the relative level of expression of the indicated gene in CD40L-
stimulated normal naive B cells.
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requirement for intact signaling through c/JAK3 down-
stream of IL-4R and IL-21R for B cell differentiation and ef-
fector function. Interestingly though, populations of IgG+ 
and IgA+ cells were detectable within the memory B cell 
subset of STAT3-deficient individuals, despite the reduction 
in total memory B cells in these patients. Because IL-21 could 
induce CD40L-activated STAT3MUT naive B cells to express 
AICDA, but not PRDM1, it is likely that the level of STAT3 
required to mediate class switching in naive B cells is signifi-
cantly less that that required for plasmablast formation. Thus, 
although IL-21R is indispensable for class switching in vivo, 
the residual amount of functional STAT3 in STAT3MUT naive 
B cells is sufficient to mediate IL-21–induced class switching 
in vivo. These findings demonstrate that within the same 
cell type (i.e., naive B cells) the thresholds of activation of 
STAT3 required for different biological processes (i.e., class 
switching versus plasmablast generation) are distinct, thereby 
providing a rational explanation for (a) intact class switch re-
combination but defective plasmablast formation by STAT3-
deficient naive B cells to IL-21 and (b) phenotypic differences 
between memory B cells in patients with mutations in STAT3 
or IL21R.
As a key attribute of memory B cells is their ability to re-
spond more rapidly than naive B cells, a question that arises is 
why STAT3MUT memory B cells do not increase in frequency 
over time to improve humoral immunity in AD-HIES. Be-
cause STAT3MUT memory B cells exhibit normal responses to 
IL-21 in vitro, this would suggest that availability of, or access 
to, stimulatory cytokines in vivo is limiting. We have reported 
that the proportions (Ma et al., 2012; Mazerolles et al., 2013) 
and absolute numbers (101 ± 7 cells/ml in normal donors vs. 
51.6 ± 10 cells/ml peripheral blood in STAT3 deficiency) of 
circulating CD4+CXCR5+ T cells, which like Tfh cells pres-
ent in secondary lymphoid tissues are enriched for IL-21–pro-
ducing cells (Chevalier et al., 2011), are reduced in AD-HIES 
patients. Furthermore, STAT3MUT CD4+ T cells are impaired 
in their ability to generate Tfh-like cells in vitro, thereby com-
promising IL-21–mediated help for B cell differentiation (Ma 
et al., 2012). These observations are consistent with a scenario 
whereby STAT3MUT memory B cells, despite their intact abil-
ity to respond to IL-21, are constrained in doing so in vivo be-
cause of diminished production of IL-21 by STAT3- 
deficient CD4+ T cells.
The deficit in memory B cells observed in STAT3MUT 
patients is comparable with that in other immune-deficient 
individuals, such as patients with mutations in SH2D1A 
(XLP; Ma et al., 2005, 2006), CD40LG (hyper-IgM syn-
drome; Notarangelo et al., 2006) or ICOS (common vari-
able immunodeficiency; Warnatz et al., 2006), or transplanted 
X-linked/JAK3-deficient SCID patients who retain autolo-
gous B cells (Recher et al., 2011). Although all of these latter 
conditions are characterized by reductions in serum Ig levels 
(Ma et al., 2005; Notarangelo et al., 2006; Warnatz et al., 
2006; Recher et al., 2011), serum levels of IgM, IgG, and IgA 
are normal in STAT3-deficient patients despite a generalized 
impairment in the ability to elicit sustained Ag-specific Ab 
found to not be the case. Third, because STAT1MUT B cells 
secreted less Ig in vitro over time, STAT1 may contribute to 
the function of activated memory B cells. Even if correct, the 
reduction in Ig secretion by STAT1MUT memory B cells is 
probably not physiologically significant as these patients have 
intact humoral immunity (Boisson-Dupuis et al., 2012). This 
may reflect the intact early differentiation of STAT1MUT 
naive and memory B cells in response to IL-10 and IL-21 
in vitro, the generation of normal numbers of memory B cells 
in vivo, and the ability of STAT1MUT memory B cells to 
produce sufficient quantities of specific Abs after reexposure 
to immunizing Ags or infectious pathogens. These findings 
suggest that STAT1 plays only a minor, if any, role in induc-
ing and maintaining humoral immunity. A final possibility is 
that memory B cells require less activated STAT3 to respond 
to specific cytokines than do naive B cells. Thus, the residual 
amounts of functional STAT3 in STAT3MUT B cells are suf-
ficient to mediate plasmablast differentiation induced by 
IL-10 and IL-21 in memory, but not naive, B cells. This is sup-
ported by our finding that IL-10 and IL-21 induced expres-
sion of the key PC transcription factors Blimp-1 and XBP-1 
in memory B cells at concentrations that had no effect on 
gene expression in corresponding naive B cells (Fig. 6). This, 
therefore, is our favored model, which is also consistent 
with memory B cells having a lower threshold for activa-
tion than naive B cells (Yefenof et al., 1986; Poudrier and 
Owens, 1994), which underlies their rapid response on sub-
sequent encounters with specific Ag (Ahmed and Gray, 1996; 
Rajewsky, 1996; Tangye and Tarlinton, 2009; Goodnow 
et al., 2010).
These findings also provide important insights into the 
hierarchy by which cytokines operate to induce B cell differ-
entiation. Thus, although IL-21R–deficient naive B cells 
could respond to IL-4 and IL-10 in vitro to induce key events 
required for Ig isotype switching (AICDA expression) and 
PC generation (PRDM1 and XBP1), responses to these and 
other cytokines such as BAFF and APRIL (Banchereau et al., 
1994; Litinskiy et al., 2002; Avery et al., 2003; Craxton et al., 
2003) are insufficient in vivo to compensate for a complete 
absence of IL-21/IL-21R signaling. This is indicated by 
B cells in IL-21R–deficient individuals expressing only IgM 
and IgD, with essentially no isotype-switched cells being 
detected (Fig. 7). Thus, despite IL-4 and IL-10 inducing 
AICDA expression in IL-21R–deficient B cells, a primary 
signal via the IL-21R appears to be the critical and rate-limiting 
step for B cells to undergo isotype switching, after which 
cytokines such as IL-4, IL-10, BAFF, and APRIL can coop-
erate to enhance IL-21–induced switching and B cell differ-
entiation (Litinskiy et al., 2002; Avery et al., 2003, 2008a; 
Craxton et al., 2003). This is reminiscent of the immunologi-
cal phenotype of X-linked or JAK3-deficient SCID patients 
who have undergone stem cell transplant but retain autolo-
gous (i.e., IL2RG or JAK3 mutant) B cells, inasmuch that 
these patients have significant reductions in memory B cells, 
isotype-switched B cells, and serum IgM and lack serum IgG 
and IgA (Recher et al., 2011), thereby highlighting the 
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(Good et al., 2006). Ig secretion was determined by ELISA after 4–12 d of 
culture (Bryant et al., 2007). Relative levels of antitetanus IgG in culture 
supernatants were determined by ELISA using plates precoated with tetanus 
toxoid (Sigma-Aldrich) and then detecting bound IgG (Avery et al., 2010).
Analysis of intracellular signaling. Naive and memory splenic B cells 
were cultured with F(ab)2 fragments of goat anti–human Ig (Jackson Immuno-
Research Laboratories, Inc.) for 18 h, washed, and then recultured with 
media alone, 100 ng/ml IL-21, or F(ab)2 anti-Ig for 15–30 min. Cells were 
then fixed, permeabilized, labeled with anti–phospho-STAT1, STAT3, 
STAT4, STAT5, and STAT6 mAb (Avery et al., 2008b, 2010) and analyzed 
by flow cytometry. Alternatively, cells were lysed and Western blotting was 
performed using rabbit polyclonal anti-STAT3 (C-20), anti-ERK2 (C-14), 
and anti-14.3.3 (K-19; Santa Cruz Biotechnology, Inc.); and anti-STAT3 
pY705 (3E2), anti-AKT pS473 (587F11), and anti-ERK1/2 pT202/Y204 
(Cell Signaling Technology).
Statistical analysis. Significant differences between datasets were deter-
mined using either the unpaired Student’s t test when comparing two vari-
ables or ANOVA for more than two variables (Prism; GraphPad Software).
Online supplemental material. Table S1 provides details of the patients 
analyzed in this study. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20130323/DC1.
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 Table S1. Primary immunodefi cient patients 
Disease and patient ID Mutation/genotype Age Reference
 yr 
 MSMD + viral infection (STAT1 defi ciency) 
STAT1#2 a P696S (homozygous) 18  Chapgier et al. (2009) 
STAT1#3 a P696S (homozygous) 14  Chapgier et al. (2009) 
 MSMD only (STAT1 defi ciency) 
STAT1#4 Q463H/WT 10  Chapgier et al. (2006) 
STAT1#5 L706S/WT 5  Chapgier et al. (2006) 
STAT1#9 E320Q/WT 4  Chapgier et al. (2006) 
STAT1#10 b Y701C/WT 40  Hirata et al. (2013) 
STAT1#11 b Y701C/WT 5  Hirata et al. (2013) 
STAT1#12 M654K/WT 7  Sampaio et al. (2012) 
STAT1#13 p.F378_R379del/WT 30  Sampaio et al. (2012) 
 AD-HIES 
STAT3#1 R382Q/WT 20  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#2 V637M/WT 21  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#3 R382Q/WT 17  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#4 H437P/WT 11  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#5 Q644P/WT 46  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#6 S465F/WT 13  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#7 Y657N/WT 48  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#8 R382W/WT 10  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#9 c L706M/WT 23  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#10 c L706M/WT 49  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#11 R382W/WT 15  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#13 d V463del/WT 18  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#14 d V463del/WT 41  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#15 R593P/WT 14  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#16 V463del/WT 37  Ma et al. (2008 ,  2012) ,  Avery et al. (2010) , and  Ives et al. (2013) 
STAT3#17 F621L/WT 3  Ives et al. (2013) 
STAT3#18 F384L/WT 9  Chandesris et al. (2012) 
STAT3#19 S614G/WT 7  Chandesris et al. (2012) 
STAT3#20 R382W/WT 16  Chandesris et al. (2012) 
STAT3#21 F384S/WT 41  Holland et al. (2007) 
STAT3#22 T622I/WT 62  Holland et al. (2007) 
STAT3#23 R382W/WT 27  Holland et al. (2007) 
STAT3#24 V637M/WT 28  Holland et al. (2007) 
STAT3#25 V463del/WT 40  Holland et al. (2007) 
STAT3#26 F621V 45  Holland et al. (2007) 
STAT3#27 R382Q/WT 50  Holland et al. (2007) 
STAT3#28 V637M/WT 43  Holland et al. (2007) 
 IL-21R defi ciency 
IL-21R#1 e C81_H82del (homozygous) 9  Kotlarz et al. (2013) 
IL-21R#2 e C81_H82del (homozygous) 13  Kotlarz et al. (2013) 
IL-21R#3 W138S (homozygous) 15.5  Ives et al. (2013) 
MSMD, Mendelian susceptibility to mycobacterial disease.
 a Related individuals.
 b Related individuals.
 c Related individuals.
 d Related individuals.
 e Related individuals.
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